CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

Edward E S Nieuwenhuis1, Tetsuya Matsumoto, Mark Exley

  • 1Gastroenterology Division and Laboratory of Mucosal Immunology, Harvard Medical School, Boston, Massachusetts, USA.

Nature Medicine
|June 4, 2002
PubMed

Insights

CD1d-restricted T cells are crucial for fighting Pseudomonas aeruginosa lung infections. Activating these cells enhances macrophage antimicrobial activity and bacterial clearance at mucosal surfaces.

Area of Science:

  • Immunology
  • Microbiology
  • Pulmonology

Background:

  • CD1d-restricted T cells are vital for host defense against microbial infections.
  • Their specific role in mucosal immunity, particularly in the lungs, remains unclear.

Purpose of the Study:

  • To investigate the role of CD1d-restricted T cells in host defense against Pseudomonas aeruginosa pneumonia.
  • To elucidate the mechanisms by which these cells influence macrophage antimicrobial functions at the lung mucosal surface.

Main Methods:

  • A murine pneumonia model using intranasal Pseudomonas aeruginosa.
  • Comparison of bacterial eradication and inflammatory responses in CD1d(-/-) mice versus wild-type mice.
  • Assessment of immune cell activity and cytokine production following alpha-galactosylceramide treatment.

Main Results:

  • CD1d(-/-) mice exhibited impaired pulmonary clearance of P. aeruginosa.
  • Reduced levels of macrophage inflammatory protein-2 and fewer neutrophils were observed in CD1d(-/-) mice.
  • Activation of CD1d-restricted T cells with alpha-galactosylceramide increased interferon-gamma and enhanced macrophage phagocytosis of P. aeruginosa.

Conclusions:

  • CD1d-restricted T cells play a critical role in controlling P. aeruginosa infections at the lung mucosal surface.
  • These T cells regulate macrophage antimicrobial functions, contributing to effective bacterial clearance.
  • Targeting CD1d-restricted T cells may offer a therapeutic strategy for respiratory tract infections.